You can learn more about our research and development through scientific publications and presentations from the Aeglea team and our collaborators.

Select a Program

March 2022

Arginase 1 Deficiency: Using Genetic Databases as a Tool to Establish Global Prevalence

December 2021

Treatment Outcomes with Pegzilarginase Compared with Standard of Care for Patients with Arginase 1 Deficiency

November 2021

Diagnosis of Arginase 1 Deficiency in a Patient With Cerebral Palsy

November 2021

Diagnosis and Long Term Treatment of Arginase 1 Deficiency

November 2021

Arginine: The Key Driver of Pathophysiology and Progression in Arginase 1 Deficiency

November 2021

Patient Characteristics in the Pivotal Phase 3 PEACE Trial of Pegzilarginase Human Enzyme Therapy for Arginase 1 Deficiency

November 2021

Management and Progression of Arginase 1 Deficiency Over 2 Decades of Follow Up

November 2021

Arginase 1 Deficiency (ARG1-D) Presenting With Clotting Abnormalities

September 2021

July 2021

Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiency

Get In Touch With Us